| Entry |
|
|---|
| Name |
Ivacaftor (USAN/INN);
Kalydeco (TN) |
|---|
| Product |
|
|---|
| Formula |
C24H28N2O3
|
|---|
| Exact mass |
392.21
|
|---|
| Mol weight |
392.4907
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Product (mixture): | D10685<US> D11042<US> D11700<US> |
|
|---|
| Efficacy |
Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator |
|---|
| Disease |
Cystic fibrosis (CFTR mutation) [DS: H00218] |
|---|
| Comment |
CFTR gene mutations: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R
|
|---|
| Target |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R07 OTHER RESPIRATORY SYSTEM PRODUCTS
R07A OTHER RESPIRATORY SYSTEM PRODUCTS
R07AX Other respiratory system products
R07AX02 Ivacaftor
D09916 Ivacaftor (USAN/INN) <US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Cystic Fibrosis Agents
Conductance Regulator Potentiator
Ivacaftor
D09916 Ivacaftor (USAN/INN)
Target-based classification of drugs [BR:br08310]
Transporters
ABC transporters
ABCC subfamily
CFTR (ABCC7)
D09916 Ivacaftor (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09916
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09916
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09916
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D09916
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 29
1 C8x C 7.4900 -23.8000
2 C8x C 7.4900 -22.4000
3 C8x C 8.6800 -21.7000
4 C8y C 9.9400 -22.4000
5 C8y C 9.9400 -23.8000
6 C8x C 8.6800 -24.5000
7 C8y C 11.1300 -21.7000
8 C8y C 12.3200 -22.4000
9 C8x C 12.3200 -23.8000
10 N4x N 11.1300 -24.5000
11 C5a C 13.5100 -21.7000
12 N1b N 14.7000 -22.4000
13 C8y C 15.8900 -21.7000
14 O5a O 13.5100 -20.3000
15 O5x O 11.1300 -20.3000
16 C8x C 15.8900 -20.3000
17 C8y C 17.1500 -19.6000
18 C8y C 18.3400 -20.3000
19 C8x C 18.3400 -21.7000
20 C8y C 17.1500 -22.4000
21 C1d C 17.1500 -23.8000
22 C1a C 18.3400 -24.5000
23 C1a C 15.9600 -24.5000
24 C1a C 17.1500 -25.2000
25 O1a O 17.1500 -18.2000
26 C1d C 19.5300 -19.6000
27 C1a C 20.7200 -20.3000
28 C1a C 19.5300 -18.2000
29 C1a C 20.7900 -18.9000
BOND 31
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 2
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 5 10 1
12 8 11 1
13 11 12 1
14 12 13 1
15 11 14 2
16 7 15 2
17 13 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 13 20 2
23 20 21 1
24 21 22 1
25 21 23 1
26 21 24 1
27 17 25 1
28 18 26 1
29 26 27 1
30 26 28 1
31 26 29 1
|
|---|
